This issue of Behavioral Health Industry Insights details the impact of deinstitutionalization and the IMD Exclusion on the behavioral healthcare landscape. On April 25, 2016, the CMS issued a long-awaited official rule meaningfully changing the IMD Exclusion provisions in response to access concerns over inpatient psychiatric and substance use disorder services.
Stay Ahead with Kroll
Mergers and Acquisitions (M&A) Advisory
Kroll’s top ranked M&A Advisory practice spans sell-side, buy-side, due diligence, deal strategy and structuring, and capital raising.
Financial Sponsors Group
Dedicated coverage and access to M&A deal-flow for financial sponsors.
Transaction Advisory Services
Kroll provides comprehensive due diligence, operational insights, and tax structuring support, assisting private equity firms and corporate clients throughout the deal lifecycle.